American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...
Issuer: CureVac / Key word(s): Patent CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech 11.07.2024 / 13:00 CET/CEST The issuer is solely ...
Pfizer (NYSE: PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the first to launch a coronavirus vaccine. That ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback